INFUSYSTEM HOLDINGS, INC Business Combination, Consideration Transferred
INFUSYSTEM HOLDINGS, INC (INFU) reported Business Combination, Consideration Transferred of $8.72 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred
us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2023-03-16
- INFUSYSTEM HOLDINGS, INC business combination, consideration transferred for the quarter ending 2022-09-30 was $0.00.
- INFUSYSTEM HOLDINGS, INC business combination, consideration transferred for the quarter ending 2021-12-31 was -$2.00K.
- INFUSYSTEM HOLDINGS, INC business combination, consideration transferred for fiscal 2021 was $8.72M.
| Period end | Business Combination, Consideration Transferred 3 month | Business Combination, Consideration Transferred 5 month | Business Combination, Consideration Transferred 6 month | Business Combination, Consideration Transferred 9 month | Business Combination, Consideration Transferred 12 month |
|---|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $8.72M 10-Q · filed 2022-11-08 | |||
| 2022-06-30 | $8.72M 10-Q · filed 2022-08-04 | ||||
| 2021-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $8.72M 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $8.73M 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | $8.73M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |